Skip to content

A Group-based Cognitive-Behavioural intervention to treat sleep disorders that negatively impact mood, daily functioning and externalising behaviour in adolescents.

The effect of a group based cognitive behaviour therapy intervention on sleep quality and actigraphy in teenagers with sleep disorders

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609001024235
Enrollment
65
Registered
2009-11-25
Start date
2010-01-10
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Sleep problems are common during adolescence and have a significant impact on the daily functioning and future potential of young people. This project evaluates the effectiveness of Cognitive-Behavioural Treatment (CBT) for sleep disorders in high-school aged young persons. Young people will take part in a randomised controlled trial in which they will be randomly allocated to complete a 7-week group-based Cognitive-Behavioural program for sleep or a 7-week waitlist control condition. Participants allocated to the waitlist condition will be asked to wait 7 weeks and be assessed again prior to beginning treatment. The effect of treatment will be measured on young persons’ sleep, mood, daily functioning, externalising behaviour and quality of life immediately after completing treatment and 3 months later. Hypotheses: We expect that compared with the no-treatment waitlist group, young people that complete CBT will show: 1) Improved sleep/wake behaviour, including less time to fall asleep, longer total sleep duration, fewer night-time awakenings, and more consolidated sleep. 2) Improved daytime functioning including less reported daytime sleepiness and fatigue. 3) Improved anxiety and depression symptomatology. 4) Improved quality of life. 5) Reduced externalising difficulties on questionnaire measures of disruptive, aggressive and delinquent behaviours. It is expected that treatment gains will be maintained at 3 month follow up.

Interventions

Adolescents with sleep disorders will be randomly allocated to a 7-week Cognitive Behavioural Therapy (CBT) program for sleep disorders, or a 7-week no-treatment waitlist control condition. The treatment involves 4 structured 2hr group sessions administered by a psychologist or clinical psychologist. Session 1 focuses on rapport building, goal setting, and sleep psychoeducation. Session 2 focuses on changing sleep behaviour (stimulus control and sleep restriction). Session 3 focuses on changing

Adolescents with sleep disorders will be randomly allocated to a 7-week Cognitive Behavioural Therapy (CBT) program for sleep disorders, or a 7-week no-treatment waitlist control condition. The treatment involves 4 structured 2hr group sessions administered by a psychologist or clinical psychologist. Session 1 focuses on rapport building, goal setting, and sleep psychoeducation. Session 2 focuses on changing sleep behaviour (stimulus control and sleep restriction). Session 3 focuses on changing negative thoughts, attitudes and beliefs about sleep. Session 4 aims to tailor the program to the individual, allow for problem solving and information about relapse prevention

Sponsors

Woolcock Institute of Medical Research
Lead SponsorOther

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
12 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

Participants will be high-school age adolescents (12 to 17 years) diagnosed with a sleep disorder (and who do not meet exclusion criteria)

Exclusion criteria

The study will exclude individuals with: i. a primary diagnosis of Delayed Sleep Phase Syndrome (DSPS), Restless leg syndrome, obstructive sleep apnoea, cataplexy and narcolepsy plus frequent parasomnias occurring more than 3 times per week. ii. comorbid psychiatric conditions, where severity is judged to interfere with the ability to benefit from group-based therapy (e.g., unmanaged psychotic or suicidal behaviour). iii. pervasive developmental disorders and those in abusive environments.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026